CBD foods get early look from Thai firms anticipating cannabis changes
The largest private company in Thailand has its eyes on CBD foods as the nation decriminalizes marijuana and hemp.
GlaxoSmithKline unit inks CBD pill deal with marijuana company Cann
Cann Group Limited, an Australian cannabis producer, said it has entered into an exclusive evaluation and option deal with GSK Consumer Healthcare, a subsidiary of U.K. drugmaker GlaxoSmithKline.
Australian cannabis firm Little Green Pharma to ‘demerge’ psychedelics unit
Australian cannabis producer Little Green Pharma says it plans to “demerge” the ownership of its psychedelics unit, Reset Mind Sciences, so the respective companies can pursue their strategies as independent businesses.
Australian cannabis company to enter US through $21 million CBD acquisition
Creso Pharma said it is buying Colorado-based CBD maker Sierra Sage Herbs in an all-stock deal worth $21 million, positioning the Australian cannabis producer to enter the U.S. market.
Australia’s new cannabis import rules could leave non-GMP producers in the cold
Australia’s Department of Health, preparing to overhaul its medical cannabis regulations, is poised to require that all products imported into the country’s small but growing market be produced in accordance with Good Manufacturing Practice (GMP).
Metrc acquires Guam’s marijuana track-and-trace contract
Marijuana track-and-trace service Metrc signed a contract to provide seed-to-sale traceability services to the U.S. territory of Guam, the Florida-based company said Monday.
MediPharm gets Australian government grant for cannabis project
The Australian subsidiary of Barrie, Ontario-headquartered MediPharm Labs received a government grant worth 466,577 Australian dollars ($352,000) to help fund a capacity optimization project at its cannabis extraction facility in Wonthaggi, Victoria.
